For dying cancer patients who have run out of therapeutic options, getting hold of drugs that are still in trials can offer them a last throw of the dice. Yet many find the system for getting early access to drugs, for so-called compassionate use’, is beset by obstacles and delays. They want a greater sense of urgency and a greater say.
Leave a Reply